J. Warren Huff
2016
In 2016, J. Warren Huff earned a total compensation of $4.6M as Chief Executive Officer at REATA PHARMACEUTICALS, a 478% increase compared to previous year.
Compensation breakdown
| Bonus | $306,000 |
|---|---|
| Option Awards | $3,798,834 |
| Salary | $450,000 |
| Total | $4,554,834 |
Huff received $3.8M in option awards, accounting for 83% of the total pay in 2016.
Huff also received $306K in bonus and $450K in salary.
Rankings
In 2016, J. Warren Huff's compensation ranked 1,859th out of 14,075 executives tracked by ExecPay. In other words, Huff earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,859 out of 14,075 | 87th |
Division Manufacturing | 632 out of 5,486 | 89th |
Major group Chemicals And Allied Products | 179 out of 1,900 | 91st |
Industry group Drugs | 126 out of 1,543 | 92nd |
Industry Pharmaceutical Preparations | 99 out of 1,173 | 92nd |
Source: SEC filing on April 24, 2017.
Huff's colleagues
We found two more compensation records of executives who worked with J. Warren Huff at REATA PHARMACEUTICALS in 2016.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019